崙棫堛栻昳怘昳塹惗尋媶強 |
National Institute of Health Sciences |
惗暔栻昳晹 |
Division of Biological Chemistry and Biologicals |
|
丂丂丂 |
亂rINN亃girentuximab (List 63, 2010, Vol.24, No. 1, p57)
亂pINN亃girentuximab (List 101, 2009, Vol.23, No. 2, p147)
亂夝愢乮榓栿乯亃
IgG1內, 峈僸僩扽巁扙悈峺慺IX(TGFB丆TGFbeta枖偼TGF-beta丏TGF-beta-1枖偼TGFB1, TGF-beta-2丆TGFB2枖偼G-TsF丆媦傃TGF-beta-3枖偼TGFB3傪娷傓),
僉儊儔儌僲僋儘乕僫儖峈懱; 峈庮釃栻丏
H嵔 (兞1嵔丆1-449)丗[Mus musculus VH (IGHV5-6-2*01 -(IGHD)-IGHJ4*01) [8.8.12]
(1-119) -Homo sapiens IGHG1*01 (120-449)]丏
L嵔(內嵔丆1'-214')丗[Mus musculus V-KAPPA (IGKV6-13*01 -IGKJ1*01) [6.3.9] (1'-107')
-Homo sapiens IGKC*01 (108'-214')]丏
僕僗儖僼傿僪寢崌偺埵抲丗222-214', 228-228''丆231-231''
摐嵔晅壛埵抲 299, 299''
亂暘巕幃亃C6460H10006N1718O2018S48
亂CAS斣崋亃916138-87-9
亂JAN亃枹廂嵹
|
|
Copyright (C) 丂丂丂Division of Biological Chemistry and Biologicals丂丂丂All
rights reserved. |
|
|